These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2877341)

  • 21. Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
    Lemay A
    Fertil Steril; 1987 Jul; 48(1):10-2. PubMed ID: 2954859
    [No Abstract]   [Full Text] [Related]  

  • 22. [GnRH analogues and myomas: against but...].
    Fernandez H
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1019-22. PubMed ID: 16314135
    [No Abstract]   [Full Text] [Related]  

  • 23. Rationale for the short-term use of luteinising hormone-releasing hormone analogues in the treatment of uterine myomata.
    Stovall TG
    Horm Res; 1989; 32 Suppl 1():134-6. PubMed ID: 2693324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [GnRH analogues and myomas: which strategy?].
    Poncelet C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1018. PubMed ID: 16316770
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging.
    Williams IA; Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):111-7. PubMed ID: 2137421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leuprolide depot before myomectomy.
    Fribourg S
    Fertil Steril; 1990 Apr; 53(4):754. PubMed ID: 2108064
    [No Abstract]   [Full Text] [Related]  

  • 27. Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas.
    De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS
    Hum Reprod; 1997 Feb; 12(2):357-60. PubMed ID: 9070725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analogs of gonadoliberin in the treatment of endometriosis and uterine myoma. Comparison of daily subcutaneous treatment and intramuscular depot therapy].
    Horský J; Cerný M; Dvorák P; Lepová B; Zizkovský V; Vondrácek J
    Cesk Gynekol; 1989 Aug; 54(7):486-95. PubMed ID: 2529980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short-term therapy of uterine fibromyomatosis with GN-Rh analog].
    Massacesi M; Milkowski M; Gianfranceschi C; Massacesi L
    Minerva Ginecol; 1992 Dec; 44(12):641-4. PubMed ID: 1491772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of LH-RH agonists in uterine leiomyoma].
    Maheux R
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(5):603-6. PubMed ID: 2212519
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
    Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
    Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of uterine leiomyomata by LH-RH agonists.
    Blumenfeld Z
    Recent Results Cancer Res; 1992; 124():19-31. PubMed ID: 1615216
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy.
    Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY
    J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical management of fibroids.
    Baird DT; West CP
    Br Med J (Clin Res Ed); 1988 Jun; 296(6638):1684-5. PubMed ID: 3135875
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
    Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.